Stay updated on Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial

Sign up to get notified when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The clinical trial record for metastatic Merkel cell carcinoma is available, with details on the nivolumab/ipilimumab treatment arms, optional SBRT, eligibility, and study outcomes. The study is active but no longer recruiting participants.
    Difference
    56%
    Check dated 2026-11-10T22:54:24.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-03T22:54:39.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide NIH notice about using “Super Intelligence” in place of “Artificial Intelligence” appears above the page, which still shows a 403 error. The site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:08:22.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The study record continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:02:05.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error page. This replaces the study details and navigation with an access-denied screen.
    Difference
    19%
    Check dated 2026-09-22T22:37:09.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.6 to v3.7.0, signaling a platform update. No study details or page content appear to be altered by this change.
    Difference
    0.1%
    Check dated 2026-09-15T22:05:03.000Z thumbnail image

Stay in the know with updates to Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.